Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a drug compound and AI integration in biotech.

Jun 2, 2026

Rakovina’s Rx: AI and Austerity Fuel a Biotech Turnaround

Rakovina Therapeutics has successfully navigated a financial turnaround by integrating AI into its drug discovery process while implementing stringent cost controls.In its recent financial report for Q1 2026, Rakovina Therapeutics showcased a notable strategic shift, merging financial austerity with a robust investment in AI-driven drug discovery. This pivot has stabilized the company, improving its balance sheet and operational efficiency. The firm reported a 23% reduction in net loss, alongsid
A flat representation of a clinical trial document

Jun 2, 2026

Argon AI Raises $5.5M To Bring Structure to Biopharma

Argon AI has successfully secured $5.5 million in funding to enhance accessibility and usability of biopharma knowledge.The startup aims to address the rising complexity within the biopharmaceutical sector, where the number of clinical trials has surged by 70% and medical literature has increased by 58% in recent years. This rapid growth presents significant challenges for professionals trying to navigate the vast amount of information available.By leveraging artificial intelligence, Argon AI se
A healthcare kiosk in an outdoor market at dusk, surrounded by people.

Jun 2, 2026

MediElaj Raises Pre-Seed Funding to Scale AI-Powered Healthcare Kiosks Across Underserved Markets

MediElaj, a healthtech startup based in Gurugram, has secured approximately $100,000 in pre-seed funding, marking a significant step toward enhancing healthcare accessibility in India through AI-powered diagnostic kiosks.The founders, Debjit Patra and Umesh Khatri, have also invested nearly $500,000 of their own funds to establish a robust technology framework for the company. MediElaj, founded in June 2023, aims to bridge the healthcare gap in underserved regions by integrating AI with smart di
A close-up of an AI algorithm on transparent film in a dimly lit lab setting.

Jun 2, 2026

If Your AI Can’t Explain Itself, Can FDA Authorize It?

Algorithmic transparency is becoming crucial for FDA evaluations of AI/ML medical devices, as manufacturers face challenges in explaining their models despite high performance metrics.As AI-powered diagnostic tools gain traction, the FDA is emphasizing the importance of understanding how these algorithms function rather than solely focusing on performance metrics like sensitivity. Manufacturers are increasingly receiving deficiency letters not for underperformance, but for failing to elucidate t
A minimalist illustration of a contract and pen in a dark palette.

Jun 2, 2026

Inside Biotech: Pro Medicus pushes back against AI fears as US deal streak powers rally

Pro Medicus Limited (ASX: PME) is experiencing a significant stock rally, fueled by recent contract wins in the U.S. and a confident outlook on artificial intelligence (AI) from management. The medical imaging software company has seen its shares rise over 6% following major contract announcements, including a seven-year, A$16 million deal with TidalHealth and a five-year renewal worth A$28 million with Allegheny Health Network. These developments are part of a broader trend, with Pro Medicus re
A stack of coins on a wooden desk in a dimly lit office, symbolizing venture capital investment.

Jun 2, 2026

UK venture capital: a market rebounding? (via Passle)

The UK venture capital landscape is witnessing a resurgence, marked by significant investment growth despite ongoing geopolitical challenges.After a period of correction following the pandemic-induced investment boom of 2021-2022, the UK venture capital sector is rebounding. In 2025, UK start-ups raised $23.6 billion, a 35% increase from the previous year, driven predominantly by late-stage financing rounds. This resurgence positions the UK as the leading destination for venture capital in Europ
A minimalist representation of a drug capsule and stomach silhouette in dark colors.

Jun 2, 2026

Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis

Dr. Falk Pharma and Renexxion are advancing naronapride into late-stage development, following promising Phase 2b results for treating gastroparesis.Renexxion, a biopharmaceutical firm focused on gastrointestinal disorders, is collaborating with Dr. Falk Pharma to progress naronapride into pivotal Phase 3 studies aimed at addressing gastroparesis. This follows encouraging outcomes from the MOVE-IT trial involving 328 patients, which demonstrated naronapride's potential to meet significant unmet
A rail track with diagnostic equipment in a railway setting

Jun 2, 2026

Siemens Mobility Expands Global Rail Diagnostics Portfolio With MERMEC Acquisition

Siemens Mobility is set to enhance its global rail diagnostics capabilities through the acquisition of key businesses from the Italian firm MERMEC Group, known for its expertise in rail technology.This acquisition encompasses MERMEC's operations in wayside signalling, electrification, telecommunications, diagnostics, and analytics, which collectively employ around 1,700 personnel and serve clients in over 70 countries. The businesses involved reportedly generated approximately EUR 430 million in
Home testing kit for STDs on a kitchen counter

Jun 2, 2026

STD Diagnostics Market Set to Reach US$ 30.84 Billion by 2033 as Early Detection and Home Testing Transform Global Sexual Healthcare

The STD diagnostics market is poised for significant growth, projected to reach $30.84 billion by 2033, driven by advancements in early detection and home testing solutions.Sexually transmitted diseases (STDs) remain a pressing global health issue, with millions diagnosed annually. The demand for effective diagnostic solutions is rising as healthcare systems strive to improve access to testing. According to market research, the STD diagnostics sector was valued at $16.82 billion in 2024 and is e
A minimalist illustration of a magnifying glass over a data point, symbolizing insights in life sciences.

Jun 2, 2026

A new AI-powered intelligence solution launches for life sciences through Prezent Vivo and Nested Knowledge

A new partnership between Prezent Vivo and Nested Knowledge aims to enhance competitive intelligence for life sciences organizations by leveraging AI-driven solutions.This collaboration merges Prezent Vivo's AI-enhanced communication platform with Nested Knowledge's automated evidence synthesis capabilities through the AutoLit® platform. The goal is to address a prevalent issue in the life sciences sector: the challenge of transforming extensive scientific and competitive data into actionable in
A vial of medication on a lab bench

Jun 2, 2026

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Salesforce has recently reported that over 140 life sciences organizations, including major players like Novartis and AstraZeneca, are utilizing its Agentforce Life Sciences platform. This announcement came during the Veeva Commercial Summit, where Salesforce emphasized its AI-driven approach across various engagement areas in the life sciences sector.Joe Ferraro, Salesforce's SVP and GM of life sciences, highlighted that their platform supports a wide array of functions, from patient and clinic
Microscope and tissue sample illustration

Jun 2, 2026

GLOBAL PATHOLOGY, DIAGNOSTICS & LABORATORY MEDICINE CONFERENCE & BUSINESS EXPO: INNOVATION, INVESTMENT, AND INDUSTRY PARTNERSHIPS

The upcoming Global Pathology, Diagnostics & Laboratory Medicine Conference & Business Expo in 2026 aims to unite professionals from various sectors within the life sciences industry, including pathologists, researchers, and healthcare providers. This event is set to be a significant platform for discussing advancements and innovations in pathology and diagnostics.The conference will feature a range of activities such as keynote speeches, scientific presentations, and interactive workshops. Thes